An ephrinA5-dependent modulation of proliferation and migration was already reported for cells with tumor initiating properties isolated from a mouse model of gliomagenesis, that relies on the loss of PTEN and p53, which represent two common genetic alterations in wild-type GBM [55]. The gene discussed is TP53; the disease is glioblastoma.